
Results
12
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
12 companies
PharmaResearch
Market Cap: ₩4.2t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩425,500.00
7D
7.9%
1Y
-37.8%
ST PharmLtd
Market Cap: ₩2.2t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩107,600.00
7D
6.2%
1Y
15.9%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,300.00
7D
8.3%
1Y
11.0%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩124,000.00
7D
-3.1%
1Y
-7.5%
Myung In Pharmaceutical
Market Cap: ₩705.9b
A pharmaceutical company, manufactures ETC and OTC drugs.
A317450
₩47,450.00
7D
5.1%
1Y
n/a
JW Holdings
Market Cap: ₩289.2b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩4,045.00
7D
6.2%
1Y
18.3%
Chong Kun Dang Holdings
Market Cap: ₩192.8b
Manufactures and distributes pharmaceutical products in South Korea and internationally.
A001630
₩39,950.00
7D
0.6%
1Y
-15.8%
Ilyang PharmaceuticalLtd
Market Cap: ₩157.7b
Operates as a pharmaceutical company primarily in South Korea.
A007570
₩8,620.00
7D
1.8%
1Y
-33.5%
Ahn-Gook Pharmaceutical
Market Cap: ₩143.2b
Manufactures and sells pharmaceutical products.
A001540
₩12,520.00
7D
-0.3%
1Y
57.9%
Sinsin Pharmaceutical
Market Cap: ₩68.0b
Manufactures and sells pharmaceutical products in South Korea.
A002800
₩4,430.00
7D
2.5%
1Y
-22.0%
RP Bio
Market Cap: ₩55.6b
A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.
A314140
₩6,310.00
7D
2.6%
1Y
-2.9%
Korean Drug
Market Cap: ₩38.2b
Manufactures and sells medicines for treating various diseases in South Korea.
A014570
₩3,495.00
7D
2.2%
1Y
-25.5%